DETAILED GENOMIC ANALYSIS
This section summarizes the genomic events detected in the tumour. Details of events reported to be associated with therapeutic, biological, prognostic and diagnostic evidence are imported from the GSC-knowledgebase. Genomic events of uncertain significance in known cancer-related genes are listed at this end of the section.
THERAPIES APPROVED IN THIS TUMOUR TYPE
No approved therapies were found for this tumour type.
THERAPIES APPROVED IN OTHER TUMOUR TYPES
No approved therapies were found for other tumour types.
ALTERATIONS WITH POTENTIAL CLINICAL RELEVANCE
KNOWN ALTERATIONS WITH THERAPEUTIC RELEVANCE
Gene: CCNA2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
24622579
Gene: CES2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
26025324
Gene: MYC
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Gain
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
15132769
Gene: PTEN
Variant: reduced expression
Source: POG098-OCT-1_trans

Expression: Down
Disease Percentile: Low
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
18332865
18332865
Gene: SKP2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
POG-unpublished
KNOWN ALTERATIONS WITH PROGNOSTIC RELEVANCE
Gene: CES2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Therapeutic Context Evidence Reference (PMID)
26025324
KNOWN ALTERATIONS WITH DIAGNOSTIC RELEVANCE
No alterations with diagnostic relevance were found from the analysis.
KNOWN ALTERATIONS WITH BIOLOGICAL RELEVANCE
Gene: APC
Variant: copy loss
Source: POG098-OCT-1

Expression: Down
Disease Percentile: Mid
Copy Number: Loss
Zygosity: het
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
14691304
Gene: CCNA2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
not specified
Gene: CES2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
26025324
Gene: EWSR1::FLI1
Variant: e7:e4
Source: POG098-OCT-1;POG098-OCT-1_trans

Expression: na
Disease Percentile: na
Copy Number: na
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
archerDx.com
cancer.sanger.ac.uk/cosmic
archerDx.com
Gene: MYC
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Gain
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
increased expression increased-function ovary
adenocarcinoma
increased-function oncogene reported 15132769
Gene: PTEN
Variant: reduced expression
Source: POG098-OCT-1_trans

Expression: Down
Disease Percentile: Low
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
reduced expression reduced-function breast cancer reduced-function tumour suppressor reported 18332865
Gene: SKP2
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
increased expression increased-function Multiple Cancers(6) increased-function cancer related gene reported 22322669
Gene: TOP2A
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
increased expression increased-function hepatocellular
carcinoma
increased-function cancer related gene reported 20371687
Gene: TP53
Variant: increased expression
Source: POG098-OCT-1_trans

Expression: Up
Disease Percentile: High
Copy Number: Neutral
Zygosity: na
Known Variant Effect Cancer Type Association Biological Context Evidence Reference (PMID)
increased expression increased-function ovary adenocarcinoma increased-function tumour suppressor reported 22699455
UNCHARACTERIZED ALTERATIONS
Gene: CHD2
Variant: p.Q366fs
Source: POG098-OCT-1;POG098-OCT-1_trans

Expression: Neutral
Disease Percentile: High
Copy Number: Neutral
Zygosity: het
Gene: HDAC7
Variant: p.A60V
Source: POG098-OCT-1;POG098-OCT-1_trans

Expression: Neutral
Disease Percentile: Low
Copy Number: Neutral
Zygosity: het
Gene: KDM5C
Variant: p.E1366*
Source: POG098-OCT-1;POG098-OCT-1_trans

Expression: Down
Disease Percentile: Low
Copy Number: Loss
Zygosity: hom
Gene: KIAA1549
Variant: p.E1802D
Source: POG098-OCT-1

Expression: Neutral
Disease Percentile: Mid
Copy Number: Neutral
Zygosity: hom
Gene: SMARCA1
Variant: p.A40V
Source: POG098-OCT-1;POG098-OCT-1_trans

Expression: Neutral
Disease Percentile: High
Copy Number: Loss
Zygosity: hom
Gene: ZNF687
Variant: p.L743fs
Source: POG098-OCT-1

Expression: Neutral
Disease Percentile: Low
Copy Number: Neutral
Zygosity: het
TARGETED GENE REPORT - DETECTED ALTERATIONS
The following alterations were detected by the Targeted Gene Report rapid analysis pipeline.
Gene: EWSR::FLI1
Variant: e7:e4
Source: POG098-OCT-1_trans